Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
30%
upside
8 price targets
|
0
%
|
|
|
|
30%
upside
8 price targets
|
0
%
|
|
|
|
29%
upside
8 price targets
|
0
%
|
|
|
504
CRISPR Therapeutics
CRSP
$5.23B
|
29%
upside
8 price targets
|
0
%
|
|
|
29%
upside
5 price targets
|
0
%
|
|
|
|
29%
upside
11 price targets
|
0
%
|
|
|
|
29%
upside
12 price targets
|
0
%
|
|
|
|
29%
upside
9 price targets
|
0
%
|
|
|
|
29%
upside
16 price targets
|
0
%
|
|
|
|
29%
upside
3 price targets
|
0
%
|
|
|
|
LAC
511
Lithium Americas
LAC
$1.37B
|
29%
upside
6 price targets
|
0
%
|
|
|
29%
upside
7 price targets
|
0
%
|
|
|
|
29%
upside
7 price targets
|
0
%
|
|
|
|
29%
upside
9 price targets
|
0
%
|
|
|
|
29%
upside
5 price targets
|
0
%
|
|
|
|
29%
upside
3 price targets
|
0
%
|
|
|
|
29%
upside
4 price targets
|
0
%
|
|
|
|
29%
upside
6 price targets
|
0
%
|
|
|
|
29%
upside
5 price targets
|
0
%
|
|
|
|
29%
upside
6 price targets
|
0
%
|
|
|
|
29%
upside
7 price targets
|
0
%
|
|
|
|
28%
upside
3 price targets
|
0
%
|
|
|
|
28%
upside
3 price targets
|
0
%
|
|
|
|
28%
upside
4 price targets
|
0
%
|
|
|
|
28%
upside
4 price targets
|
0
%
|
|